Skip to content

Clinical trials

Phase 3 Eye Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Eye Diseases Phase: Phase 3 Country / region: United Kingdom Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20162
20182
20191
20212
20221
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GenSight Biologics4
AbbVie1
Bayer1
King's College Hospital NHS Trust1
Laboratoires Thea1
Novartis Pharmaceuticals1
Ocus Innovation Ireland Limited1
Opthea Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Eye Diseases11
Eye Diseases, Hereditary5
Optic Atrophy, Hereditary, Leber5
Retinal Diseases5
Macular Degeneration4
Mitochondrial Diseases4
Wet Macular Degeneration4
Genetic Diseases, Inborn3
Nervous System Diseases3
Neurodegenerative Diseases3

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.